Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
13.98
+0.48 (3.56%)
Jul 21, 2026, 10:02 AM EDT - Market open
Summit Therapeutics Employees
Summit Therapeutics had 265 employees as of December 31, 2025. The number of employees increased by 106 or 66.67% compared to the previous year.
Employees
265
Change (1Y)
106
Growth (1Y)
66.67%
Revenue / Employee
n/a
Profits / Employee
-$4,551,309
Market Cap
10.85B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 265 | 106 | 66.67% |
| Dec 31, 2024 | 159 | 54 | 51.43% |
| Dec 31, 2023 | 105 | 28 | 36.36% |
| Dec 31, 2022 | 77 | -33 | -30.00% |
| Dec 31, 2021 | 110 | 29 | 35.80% |
| Dec 31, 2020 | 81 | 11 | 15.71% |
| Dec 31, 2019 | 70 | 9 | 14.75% |
| Dec 31, 2018 | 61 | -15 | -19.74% |
| Dec 31, 2017 | 76 | 36 | 90.00% |
| Dec 31, 2016 | 40 | 3 | 8.11% |
| Dec 31, 2015 | 37 | 14 | 60.87% |
| Dec 31, 2014 | 23 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Axsome Therapeutics | 1,220 |
| Corcept Therapeutics | 730 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 673 |
| Halozyme Therapeutics | 423 |
| Krystal Biotech | 295 |
SMMT News
- 5 days ago - Summit Therapeutics to Host Second Quarter 2026 Financial Results & Operational Progress Call on July 23, 2026 - Business Wire
- 7 days ago - Summit Therapeutics signs agreement to sell ridinilazole to Biossil - TheFly
- 7 days ago - Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc. - Business Wire
- 5 weeks ago - Summit Therapeutics withdraws proposed underwritten public offering - TheFly
- 5 weeks ago - Summit Therapeutics falls -10.2% - TheFly
- 5 weeks ago - Summit Therapeutics put volume heavy and directionally bearish - TheFly
- 5 weeks ago - Summit Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Summit Therapeutics announces $500M common stock offering - TheFly